JPS59225117A - 抗腫瘍剤 - Google Patents
抗腫瘍剤Info
- Publication number
- JPS59225117A JPS59225117A JP58099609A JP9960983A JPS59225117A JP S59225117 A JPS59225117 A JP S59225117A JP 58099609 A JP58099609 A JP 58099609A JP 9960983 A JP9960983 A JP 9960983A JP S59225117 A JPS59225117 A JP S59225117A
- Authority
- JP
- Japan
- Prior art keywords
- antitumor agent
- formula
- compound
- organic germanium
- germanium compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 title claims abstract description 16
- 150000002291 germanium compounds Chemical class 0.000 claims abstract description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 239000002075 main ingredient Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 abstract description 7
- MUDDKLJPADVVKF-UHFFFAOYSA-N trichlorogermane Chemical compound Cl[GeH](Cl)Cl MUDDKLJPADVVKF-UHFFFAOYSA-N 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 4
- CVMBLRBRUFIQFK-UHFFFAOYSA-N 2-trichlorogermylpropanamide Chemical compound NC(=O)C(C)[Ge](Cl)(Cl)Cl CVMBLRBRUFIQFK-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 6
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- -1 trichlorogermyl Chemical group 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZJUHNMADISSFJZ-UHFFFAOYSA-N 2-trichlorogermylpropanoic acid Chemical compound OC(=O)C(C)[Ge](Cl)(Cl)Cl ZJUHNMADISSFJZ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910005742 Ge—C Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010042135 Stomatitis necrotising Diseases 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000008585 noma Diseases 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical group [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- XEABSBMNTNXEJM-UHFFFAOYSA-N propagermanium Chemical compound OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O XEABSBMNTNXEJM-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical group O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000002100 tumorsuppressive effect Effects 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58099609A JPS59225117A (ja) | 1983-06-06 | 1983-06-06 | 抗腫瘍剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58099609A JPS59225117A (ja) | 1983-06-06 | 1983-06-06 | 抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59225117A true JPS59225117A (ja) | 1984-12-18 |
| JPS6158448B2 JPS6158448B2 (enrdf_load_stackoverflow) | 1986-12-11 |
Family
ID=14251833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58099609A Granted JPS59225117A (ja) | 1983-06-06 | 1983-06-06 | 抗腫瘍剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59225117A (enrdf_load_stackoverflow) |
-
1983
- 1983-06-06 JP JP58099609A patent/JPS59225117A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6158448B2 (enrdf_load_stackoverflow) | 1986-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH02500275A (ja) | 潰瘍の予防のための方法及び組成物 | |
| DE69023442T2 (de) | Verwendung einer Cyaninfarbe in einem antitumoralen Mittel. | |
| JPS6075454A (ja) | 鎮痛用新規化合物および組成物 | |
| US5538951A (en) | Pharmaceutical preparation for the therapy of immune deficiency conditions | |
| JPH0662407B2 (ja) | 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤 | |
| JPH05503077A (ja) | 抗腫瘍剤としてのイルージンアナログ | |
| CN106631957B (zh) | 一种靶向FAP-alpha酶的抗肿瘤化合物及其制备方法与应用 | |
| US3676554A (en) | Anti-arthritic compositions comprising phosphine or phosphite gold halide complexes and methods of producing anti-arthritic activity | |
| WO1988008715A1 (en) | Method of tumor inhibition in warm-blooded animals | |
| US4898882A (en) | Resistance imparting agent for cold syndrome of low pulmonary function patients | |
| DE3425404C2 (de) | Verwendung von Germaniumsesquisulfiden als Antineoplastikum | |
| US4822817A (en) | Remedy for bone disease | |
| CA1283904C (en) | Liposoluble platinum (ii) complex and preparation thereof | |
| JPS59225117A (ja) | 抗腫瘍剤 | |
| DE3424107A1 (de) | Organogermaniumverbindung und diese als wirkstoff enthaltender opioidpeptidaseinhibitor | |
| JP2000302762A (ja) | 放射線および化学療法における感受性増強剤であるグリシジアゾール金属塩、並びにそれらの製造方法および使用 | |
| HUT69710A (en) | The use of quinoline-3-carboxamide compounds for preparing pharmaceutical compositions suitable for treatment of diabetes | |
| US5560925A (en) | Method of treating wart | |
| JPS61145116A (ja) | オステオポロ−ジス治療剤 | |
| EP1414829B1 (de) | Tumorhemmende cerverbindungen | |
| EP0214862B1 (en) | Anti-tumour platinum complexes, their preparation and their use | |
| JPH01149723A (ja) | 骨芽細胞活性化剤 | |
| JPS5835186A (ja) | ジカルボキシアミノチアゾール誘導体およびそれを含有する免疫調節組成物 | |
| JPS63146813A (ja) | ジテルペン系化合物を含んで成る制癌剤 | |
| JPS5936696A (ja) | ２′―デオキシ―５―置換ウリジン誘導体及びそれを含有する抗腫瘍剤 |